The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC by Patil, Tejas, MD, Staley, Alyse, MS, Nie, Yunan, MD, Sakamoto, Mandy, MD, Stalker, Margaret, MD, Jurica, James M., MD, MBA, Koehler, Kenna, BA, Cass, Amanda, PharmD, Kuykendall, Halle, BA, Schmitt, Emily, MS, Filar, Emma, BA, Reventaite, Evelina, MS, Davies, Kurt D., PhD, Nijmeh, Hala, PhD, Haag, Mary, PhD, Yoder, Benjamin A., PharmD, Bunn, Paul A., MD, Schenk, Erin L., MD, PhD, Aisner, Dara L., MD, PhD, Iams, Wade T., MD, Marmarelis, Melina E., MD, Camidge, D. Ross, MD, PhD

Get full text

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers by Choudhury, Noura J., MD, Schneider, Jaime L., MD, PhD, Patil, Tejas, MD, Zhu, Viola W., MD, PhD, Goldman, Debra A., MS, Yang, Soo-Ryum, MD, Falcon, Christina J., XX, Do, Andrew, XX, Nie, Yunan, MD, Plodkowski, Andrew J., MD, Chaft, Jamie E., MD, Digumarthy, Subba R., MD, Rekhtman, Natasha, MD, PhD, Arcila, Maria E., MD, Iasonos, Alexia, PhD, Ou, Sai-Hong I., MD, PhD, Lin, Jessica J., MD, Drilon, Alexander, MD

Get full text